SCHEMBL1120940

SCHEMBL1120940

c1ccc2c(c1)CSCS2

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RYR2 Q92736 4/20 0.41
▸ ACHE P22303 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ GAA P10253 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B3 P37058 1/20 0.33
▸ LMNA P02545 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HTT P42858 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15761043 0.79 — —
SCHEMBL13864441 0.79 ALDH1A1 (0.47) RYR2ACHEALDH1A1HPGDMAPT
SCHEMBL4857897 0.79 RYR2 (0.48) RYR2ACHEALDH1A1HPGDMAPT
SCHEMBL2077182 0.76 TSHR (0.38) ACHEALDH1A1MEN1KMT2ATSHR
SCHEMBL121521 0.70 — —
SCHEMBL255965 0.70 — —
SCHEMBL29965099 0.70 — —
SCHEMBL7332054 0.70 — —
SCHEMBL30560010 0.70 — —
SCHEMBL9112992 0.70 HTT (0.37) MAPTTDP1MEN1KMT2AHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3885337-B1 FTO INHIBITORS NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) 2025-01-15 — — EP claimed
EP-3885337-A1 FTO INHIBITORS National Institute Of Biological Sciences, Beijing (CN) 2021-09-29 — — EP claimed
US-20210238127-A1 FTO Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-08-05 — — US claimed
US-10988440-B2 FTO inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-04-27 — — US claimed
US-20200148628-A1 FTO Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2020-05-14 — — US claimed
US-20180118665-A1 FTO Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2018-05-03 — — US claimed
EP-3303283-A1 FTO INHIBITORS National Institute Of Biological Sciences, Beijing (CN) 2018-04-11 — — EP claimed
WO-2016206573-A1 FTO INHIBITORS NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2016-12-29 — — WO claimed
EP-2662351-B1 Alkylated heterocyclic reaction products useful as antioxidants SI GROUP INC (US) 2016-03-30 — — EP claimed
EP-2084142-B1 ALKYLATED HETEROCYCLIC REACTION PRODUCTS USEFUL AS ANTIOXIDANTS SI GROUP INC (US) 2016-03-23 — — EP claimed
EP-2662351-A1 Alkylated heterocyclic reaction products useful as antioxidants Albemarle Corporation (US) 2013-11-13 — — EP claimed
US-8410084-B2 Alkylated heterocyclic reaction products useful as antioxidants ALBEMARLE CORPORATION (US) 2013-04-02 — — US claimed
WO-2000035916-A1 HERBICIDAL 4-BENZOYLISOXAZOLES AVENTIS CROPSCIENCE S.A. (FR) 2000-06-22 — — WO claimed
US-6048984-A HERBICIDES AND ANTIGROWTH AGENTS RHONE-POULENC AGRICULTURE LIMITED (GB) 2000-04-11 — — US claimed
US-5977376-A Herbicidal 2-benzoylcyclohexane-1,3-diones and related compounds RHONE-POULENC AGRICULTURE LIMITED (GB) 1999-11-02 — — US claimed
EP-0918056-A1 Herbicides RHONE-POULENC AGRICULTURE LTD. (GB) 1999-05-26 — — EP claimed
WO-1999003856-A1 4-BENZOYL-ISOXAZOLE- AND -PYRAZOLE DERIVATIVES AND 2-CYANO 1,3-DIONE DERIVATIVES AS HERBICIDES RHONE-POULENC AGRICULTURE LIMITED (GB) 1999-01-28 — — WO claimed
WO-1999003845-A1 2-BENZOYLCYCLOHEXANE-1,3-DIONE DERIVATIVES AS HERBICIDES AND INTERMEDIATES RHONE-POULENC AGRICULTURE LIMITED (GB) 1999-01-28 — — WO claimed
EP-0858452-A1 THIAZOLE DERIVATIVE AS PROTEIN KINASE C INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-08-19 — — EP claimed
WO-1998004536-A1 THIAZOLE DERIVATIVE AS PROTEIN KINASE C INHIBITORS OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1998-02-05 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118665-A1 FTO Inhibitors FTO, ALKBH3, ALKBH1 RYR2 4177/4885ACHE 2898/4885ALDH1A1 274/4885
US-20210238127-A1 FTO Inhibitors FTO, ALKBH3, ALKBH1 RYR2 4177/4885ACHE 2898/4885ALDH1A1 274/4885
US-20200148628-A1 FTO Inhibitors FTO, ALKBH3, ALKBH1 RYR2 4177/4885ACHE 2898/4885ALDH1A1 274/4885
US-10988440-B2 FTO inhibitors FTO, ALKBH3, ALKBH1 RYR2 4177/4885ACHE 2898/4885ALDH1A1 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback